Agilent Technologies Strategic Investments
Corporate venture profile
Agilent Technologies Strategic Investments is the corporate venture arm of Agilent Technologies, a healthcare company. It is based in Santa Clara, United States. It invests at the Series A stage. Sectors it names: biotech and life sciences, medical devices.
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Series A to Series A |
| Sectors | Biotech and life sciences, Medical devices |
| Geography | North America |
| Offices | Santa Clara, United States |
Sources: S2 PR Newswire: PreciseDx raises $10.75M Series A preferred.
Where it invests
Geography
- Headquarters
- Santa Clara, United States
- Offices
- Santa Clara, United States
Investment regionsS2
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | Agilent Technologies (NYSE: A) | Single source | S1 |
| Parent industry | Healthcare and life sciences | Single source | S1 |
| Headquarters | Santa Clara, United States | Single source | S1 |
| Status | Active | Single source | S1 |
| Capital source | Parent company only | Single source | S1 |
| Stages | Series A (inferred from announced rounds) | Estimate | S2 |
About Agilent Technologies
History
- Participates in PreciseDx USD 10.75M Series A (January)S2
Portfolio
Portfolio company named in public sources: PreciseDx.S2
Official pages
Read the firm's own pages for current information.
- Website www.agilent.com/
Sources
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by Agilent Technologies Strategic Investments or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.